Select the Patient's Age:
Pradaxa 110 mg bd may be considered
for patients < 75 years with:
- a potentially higher risk of major bleeding or
- moderate renal impairment (CrCl 30-50 mL/min)
Renal function must be assessed before commencing Pradaxa to exclude patients with severe
renal impairment.
Pradaxa is contraindicated in patients with severe renal impairment.
(CrCl < 30 mL/min).